-
Fda has janson TREMFYA ® One-Press for treatment of moderate to severe plaque psoriasis
Time of Update: 2020-06-10
recently http:// , the U.S FDA (http:// has approved the company's TREMFYA ® One-Press, a one-time, single-dose patient self-controlled syringe for the treatment of moderate to severe plaque psor
-
Knopp Biosciences announces oral candidate drug dexpramipexole for FDA orphan drug designation
Time of Update: 2020-06-10
high eosinophil syndrome (HES) mainly refers to the patient's blood the number of eosinophils continued to increase (the absolute number of eosinophils is greater than 0.5 x 109/L), clinical manifes
-
Baiyang Pharmaceutical metformin new drug Nida in the United States approved by the FDA
Time of Update: 2020-06-10
recently, baiyang Pharmaceutical (http:// announced that the company (http:// of high-end generic drugs, the use of osmosis pump-controlled release technology metformin new drug (http:// th
-
A new drug application from FDA's new base, Lenalidomide, to naldomide
Time of Update: 2020-06-10
recently, bio pharmaceutical (http:// giant, Http:// announced that the u.S Food and Drug (http:// Administration ( FDA ( http:// had accepted and granted priority review to a application
-
Sanofi dengue vaccine Dengvaxia has been approved by the European Commission
Time of Update: 2020-06-10
dengue fever (Dengue) is an acute insect-borne infection caused by the mosquito-borne transmission of the dengue virus Clinical manifestations of high fever, headache, muscle, bone joint severe sore
-
FDA grants Enzyvant's RVT-801 rare pediatric disease eligibility and fast-track eligibility
Time of Update: 2020-06-10
Farber disease is a rare and considered significantly underdiagnosed disease, often misdiagnosed as juvenile isopathic arthritis The disease is caused by mutations in the ASAH1 gene, which cause the
-
Advances in new research on the bioimmune anti-cancer drug YS-ON-001
Time of Update: 2020-06-10
Today, the company, the http:// Pharmaceutical (http:// Limited , announced http:// that the company's immuno-cancer drug (http:// YS-ON-001 has made new research progress, with excellent tum
-
FDA grants Agios' target cancer drug Tibsovo (ivosidenib) breakthrough drug
Time of Update: 2020-06-10
recently, the u.S leading cancer bio pharmaceutical company (http:// http:// Agios announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has granted the targeted an
-
Xi'an Yangsen Yiyi (Ibtini capsule) New indications approved by the State Drug Administration
Time of Update: 2020-06-10
today, The of Johnson and Corporation (http:// Xi'an Yangsen Pharmaceutical Co., Ltd., a subsidiary of china's Pharmaceutical (http:// announced that its new indications of Eyre (ibitini capsu
-
FDA approves Janssen Pharmaceuticals Tremfya ® One Pres for treatment in adult patients with moderate to severe plaque psoriasis
Time of Update: 2020-06-10
recently, the U.S Pharmaceutical (http:// http:// giant , , janssen Pharmaceutical (http:// announced that the U.S FDA http:// has approved Tremfya ® One Press, a single-dose, patient-co
-
FDA approves Tosymra (Shumaqutan nasal spray, 10mg) for continued treatment of migraines in adults
Time of Update: 2020-06-10
recently, Dr Reddy, of the http:// pharmaceutical in India, said: "It's not a good time Reddy's Laboratories Ltd and sub- company (http:// Promius Pharma announced that the U.S Food and Drug
-
Aerie's glaucoma drug Rocklatan (netarsudil/latanoprost) gets FDA approval
Time of Update: 2020-06-10
, a of the http:// ( http:// announced that the U.S Food and Medicines (http:// Administration ( FDA (http:// ) had approved the company's glauselsud/latanoprost eye solution, 0.02%/0.005 p
-
ADHD reaches major endpoint in two key Phase 3 clinical trials
Time of Update: 2020-06-10
ADHD, commonly known as ADHD, is a chronic brain disease that manifests itself as unable to concentrate, hyperactivity and impulsiveness today, Supernus Pharmaceuticals (http:// announced that i
-
Diabetes innovative oral therapy imeglimin successfully in a Phase 3 clinical trial
Time of Update: 2020-06-10
recently, Poxel Bio Medicines (http:// http:// and partner Sumitomo Dayou Pharmaceutical son (http:// announced the success of its innovative diabetes innovation oral therapy, imeglimin, in
-
FDA approves Pfizer Ibrance joint drug to treat male breast cancer patients
Time of Update: 2020-06-10
recently, Pfizer (http:// announced that the U.S FDA (http:// approved the company's heavy-weight breast cancer treatment Ibrcicsito in conjunction with aromatase inhibitors or fuforvestts to
-
FDA grants AK1/2 inhibitor Olumiant (baricitinib) fast-track eligibility to treat systemic lupus erythematosus
Time of Update: 2020-06-10
recently , http:// giant Eli Lilly and partner Incyte http:// announced that the u.S Food and Drug (http:// Administration ( ) of the FDA (http:// had granted JAK1/2 inhibitor, The Baricit
-
FDA grants CymaBay Therapeutics Clinical Phase 3 In Research Drug Seladelpar Breakthrough Therapy Determination
Time of Update: 2020-06-10
primary bile bile ductitis is a potentially life-threatening liver autoimmune disease As the immune system continues to attack bile ducts, bile flow is blocked and silted, toxic bile acid remains in
-
Clinical trial of YPS345, a class 1 innovative drug, was approved by the State Drug Administration
Time of Update: 2020-06-10
Today, china Pharmaceutical (http:// issued a notice that its wholly-owned subsidiary (http:// Tianfang Pharmaceutical Co., Ltd received a notice of acceptance of the clinical test (http://
-
FDA approves shire's treatment of chronic isophation of Motegroity
Time of Update: 2020-06-10
CIC is a very common disease, the main symptoms are long-term defecation difficulties and infrequent, other symptoms include abdominal pain and bloating recently, the U.S FDA (http:// announced
-
FDA approves Advair Diskus debut sugo
Time of Update: 2020-06-10
asthma is a chronic lung disease in which the airways of patients develop inflammation and narrow, leading to repeated chest tightness, shortness of breath, cough and other symptoms today, the FDA